Skip Main Navigation
Page Content

Save This Event

Event Saved

10th Annual Chabner Colloquium: Answering the Big Questions in Cancer Research

Society for Translational Oncology

Monday, November 18, 2019 from 7:00 AM to 2:30 PM (EST)

10th Annual Chabner Colloquium: Answering the Big...

Ticket Information

Ticket Type Sales End Price Fee Quantity
Industry Representatives Nov 15, 2019 $350.00 $0.00
Physicians Nov 15, 2019 $150.00 $0.00
Healthcare Professionals, Patient Advocates/Caregivers and Government Employees Nov 15, 2019 $75.00 $0.00

Share 10th Annual Chabner Colloquium: Answering the Big Questions in Cancer Research

Event Details

Founded by Dr. Bruce A. Chabner, this annual symposium, presented in joint partnership with the Massachusetts General Hospital Cancer Center, encourages dialogue among experts on topics that bring cancer biology to clinical application. The Chabner Colloquium is an intensive and thoughtful look at the potential for rational, collaborative drug development, tapping into the resources of government, pharmaceutical and biotech companies, and globally statured cancer centers of excellence.

Focusing on new targets and their interventions; strategies for profiling and selection of patients for targeted drug trials; and biomarkers and animal models to guide clinical development, the entire drug development process is represented. The Chabner Colloquium provides a dialogue that influences trial design, hastens cancer drug development, and, long-term, will rationalize and lend efficiency to the practice of oncology.

Have questions about 10th Annual Chabner Colloquium: Answering the Big Questions in Cancer Research? Contact Society for Translational Oncology

Save This Event

Event Saved

When & Where


Wyndham Boston Beacon Hill
5 Blossom Street
Boston, MA 02114

Monday, November 18, 2019 from 7:00 AM to 2:30 PM (EST)


  Add to my calendar

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.